A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds

AM Sawayama, MMY Chen…

Index: Chemistry - A European Journal, , vol. 15, # 43 p. 11723 - 11729

Full Text: HTML

Citation Number: 90

Abstract

... E-mail address: frances@cheme.caltech.edu. Division of Chemistry and Chemical Engineering 210-41 ... Selective C H oxidation represents one of the great challenges for which synthetic chemists find only very substrate-specific solutions.1–4 Breakthroughs in selective C H ...

Related Articles:

Design, synthesis and evaluation of 9-hydroxy-7H-furo [3, 2-g] chromen-7-one derivatives as new potential vasodilatory agents

[Wang, Cheng; Wang, Tao; Zhou, Nan; Pan, Xiao-Yan; He, Huai-Zhen Journal of Asian Natural Products Research, 2014 , vol. 16, # 3 p. 304 - 311]

Antagonistes calciques. I. Remplacement du groupe diméthoxy-3, 4 phényléthyle du vérapamil

[Laguerre, M.; Boyer, C.; Carpy, A.; Panconi, E.; Cognic, F.; Vaugien, B. European Journal of Medicinal Chemistry, 1990 , vol. 25, # 4 p. 351 - 359]

Antagonistes calciques. I. Remplacement du groupe diméthoxy-3, 4 phényléthyle du vérapamil

[European Journal of Medicinal Chemistry, , vol. 25, # 4 p. 351 - 359]

Antagonistes calciques. I. Remplacement du groupe diméthoxy-3, 4 phényléthyle du vérapamil

[European Journal of Medicinal Chemistry, , vol. 25, # 4 p. 351 - 359]

Comparison of triple quadrupole, hybrid linear ion trap triple quadrupole, time??of??flight and LTQ??Orbitrap mass spectrometers in drug discovery phase metabolite …

[Rapid Communications in Mass Spectrometry, , vol. 24, # 7 p. 939 - 957]

More Articles...